Skip to main content

Table 1 Fatty acid composition (% of total fatty acids) of control and experimental diets

From: Increased hypolipidemic benefits of cis-9, trans-11 conjugated linoleic acid in combination with trans-11 vaccenic acid in a rodent model of the metabolic syndrome, the JCR:LA-cp rat

Fatty acid

Control diet (CD)

CLA diet

VA+CLA diet

C16:0

9.1

8.5

9.1

C18:0

47.3

46.9

44.3

18:1 t- 11 (VA)

ND

ND

5.6

18:1 c- 9 (OA)

17.3

11.4

10.5

18:1 c- 11

ND

0.5

0.5

C18:2 n6 (LA)

23.3

23.4

20.4

C18:3 n3 (ALA)

1.6

1.7

1.6

CLA c- 9, t- 11

0

5.2

3.9

CLA t- 10, c- 12

ND

1.1

0.8

other CLA

ND

0.3

0.3

Summary

   

∑ total SFA2

57.2

56.3

54.2

∑ C12:0, C14:0, C16:03

9.1

8.5

9.1

∑ cis MUFA4

17.4

12.0

11.1

∑ PUFA5

25.0

25.1

22.0

∑ n-6 PUFA

23.4

23.4

22.0

∑ n-3 PUFA

1.6

1.7

1.6

P/S ratio6

0.4

0.4

0.4

∑ CLA

0.0

6.6

5.0

  1. 1. No detectable
  2. 2 Sum of all saturated fatty acids
  3. 3 Sum of lauric, myristic and palmitic acids
  4. 4 cis MUFA, sum of all monounsaturated excepting trans fatty acids
  5. 5 Sum of all polyunsaturated fatty acids excepting CLA
  6. 6 Ratio of polyunsaturated to saturated fatty acids